IBS with Constipation (IBS-C): Treatment Options Explained

What makes IBS-C different from ordinary constipation?

In IBS with constipation, abdominal pain is the defining feature — not just slow or difficult stooling. The pain is linked to the constipation: it typically worsens before a bowel movement and improves (or changes) afterward. Bloating and a sense of incomplete evacuation are also common 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C.

This distinguishes IBS-C from chronic idiopathic constipation, where abdominal pain may not be prominent. The distinction matters because some treatments are specific to one condition. Both the ACG's 2021 IBS guideline and the AGA's 2022 pharmacological guideline for IBS-C emphasize that the pain component — not just stool frequency — should guide treatment choice 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C2Ref 2Chang L, Sultan S, Lembo A, Verne GN, Smalley W, Heidelbaugh JJ (2022).AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.Strong recommendations for linaclotide and plecanatide; osmotic laxatives for stool but limited pain evidence; lubiprostone for IBS-C in women.

What dietary and lifestyle approaches help IBS-C?

Before reaching for any medication, several non-pharmacological strategies are worth trying 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (2024).Irritable Bowel Syndrome (IBS).IBS as a disorder of gut-brain interaction; treatment overview including diet, medications, probiotics, and mental health therapies:

Soluble fiber: The ACG guideline conditionally recommends soluble fiber (such as psyllium/ispaghula husk) over insoluble fiber for IBS. Soluble fiber softens stool and slows transit in a balanced way. Insoluble fiber (wheat bran) can worsen bloating in some IBS-C patients 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C.

Hydration: Adequate fluid intake supports stool softness, especially when fiber intake is increased.

Physical activity: Regular movement stimulates gut motility; modest, consistent exercise is sufficient 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (2024).Irritable Bowel Syndrome (IBS).IBS as a disorder of gut-brain interaction; treatment overview including diet, medications, probiotics, and mental health therapies.

Low-FODMAP diet: Some people with IBS-C find that reducing high-FODMAP foods reduces bloating and improves overall bowel comfort 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C.

Consistent toilet habits: Establishing a regular time to attempt a bowel movement — particularly after meals when the gastrocolic reflex is active — can help.

What over-the-counter options are available for IBS-C?

Osmotic laxatives (polyethylene glycol, magnesium-based) draw water into the stool and colon. While not specifically approved for IBS-C, they are commonly used and can soften stool. The AGA guideline notes that osmotic laxatives may improve stool consistency but have less evidence for the abdominal pain component of IBS-C than prescription agents 2Ref 2Chang L, Sultan S, Lembo A, Verne GN, Smalley W, Heidelbaugh JJ (2022).AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.Strong recommendations for linaclotide and plecanatide; osmotic laxatives for stool but limited pain evidence; lubiprostone for IBS-C in women.

Psyllium supplements (Metamucil and generics) provide soluble fiber without prescription 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C.

Docusate sodium (stool softener): Limited evidence specifically in IBS-C.

Over-the-counter stimulant laxatives (bisacodyl, senna) may provide short-term relief but are not recommended for regular use in IBS-C without medical guidance 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (2024).Irritable Bowel Syndrome (IBS).IBS as a disorder of gut-brain interaction; treatment overview including diet, medications, probiotics, and mental health therapies.

What prescription medications are used for IBS-C?

The AGA's 2022 guideline on pharmacological management of IBS-C evaluated several prescription options and provides the following strong recommendations 2Ref 2Chang L, Sultan S, Lembo A, Verne GN, Smalley W, Heidelbaugh JJ (2022).AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.Strong recommendations for linaclotide and plecanatide; osmotic laxatives for stool but limited pain evidence; lubiprostone for IBS-C in women:

Secretagogues — increase fluid secretion into the intestine, softening stool and stimulating motility: - Linaclotide and plecanatide: FDA-approved for IBS-C. They also have direct pain-reducing effects in the gut, making them particularly suited for IBS-C where pain is central. The AGA guideline gives these a strong recommendation 2Ref 2Chang L, Sultan S, Lembo A, Verne GN, Smalley W, Heidelbaugh JJ (2022).AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.Strong recommendations for linaclotide and plecanatide; osmotic laxatives for stool but limited pain evidence; lubiprostone for IBS-C in women. - Lubiprostone: Also FDA-approved for IBS-C in women. Works by activating chloride channels to increase intestinal fluid.

Low-dose antidepressants (tricyclics): Sometimes used for their pain-modulating effects on the gut — useful when anxiety or pain is prominent — at sub-antidepressant doses 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C.

Your gastroenterologist will choose based on your symptom pattern, other health conditions, and current medications.

How long does treatment take to work?

Dietary changes often show results within 2–4 weeks 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (2024).Irritable Bowel Syndrome (IBS).IBS as a disorder of gut-brain interaction; treatment overview including diet, medications, probiotics, and mental health therapies. Prescription secretagogues typically improve stool frequency within 1–2 weeks, with pain relief developing over 4–8 weeks. If a treatment is not working after a reasonable trial, your gastroenterologist may adjust the approach.

IBS-C is a chronic condition for many people, meaning ongoing management rather than a one-time cure. Regular follow-up with a gastroenterologist helps adjust the plan as symptoms change 1Ref 1Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B (2021).ACG Clinical Guideline: Management of Irritable Bowel Syndrome.Soluble fiber preference over insoluble; low-FODMAP diet; overall pharmacological framework and tricyclic antidepressants for IBS-C.